Dosimetric explanations of fatigue in head and neck radiotherapy: An analysis from the PARSPORT Phase III trial

Radiotherapy and Oncology

Volumn 104, Issue 2, 2012, Pages 205-212

  Gulliford, Sarah L ^a   Miah, Aisha B ^b   Brennan, Sinead ^c   McQuaid, Dualta ^a,b   Clark, Catharine H ^d,e   Partridge, Mike ^a   Harrington, Kevin J ^a,b   Morden, James P ^a   Hall, Emma ^a   Nutting, Christopher M ^a,b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c ST LUKE S HOSPITAL   (Ireland)

^d ROYAL SURREY COUNTY HOSPITAL   (United Kingdom)

^e NATIONAL PHYSICAL LABORATORY   (United Kingdom)

Author keywords

CNS; Fatigue; Head and neck; IMRT; Radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; BASAL GANGLION; BRAIN STEM; CENTRAL NERVOUS SYSTEM; CEREBELLUM; DOSIMETRY; FATIGUE; FEMALE; HIPPOCAMPUS; HUMAN; HYPOPHYSIS; HYPOTHALAMUS; INCIDENCE; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PHASE 3 CLINICAL TRIAL (TOPIC); PINEAL BODY; POSTERIOR FOSSA; PRIORITY JOURNAL; RADIATION DOSE;

AGED; CENTRAL NERVOUS SYSTEM; DOSE-RESPONSE RELATIONSHIP, RADIATION; FATIGUE; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PAROTID NEOPLASMS; RADIOMETRY; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RISK ASSESSMENT; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84865800392     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2012.07.005     Document Type: Article

References (33)

1. L.I. Wagner, and D. Cella Fatigue and cancer: causes, prevalence and treatment approaches Br J Cancer 91 2004 822 828
2. K. Ahlberg, T. Ekman, F. Gaston-Johansson, and V. Mock Assessment and management of cancer-related fatigue in adults Lancet 362 2003 640 650
3. E.M. Smets, M.R. Visser, and A.F. Willems-Groot Fatigue and radiotherapy: (A) experience in patients undergoing treatment Br J Cancer 78 1998 899 906
4. A. Purcell, J. Fleming, S. Bennett, K. McGuane, B. Burmeister, and T. Haines A multidimensional examination of correlates of fatigue during radiotherapy Cancer 116 2010 529 537
5. DCTD, NCI NIH, Cancer Therapy Evaluation Program. Common terminology criteria for adverse events v 3.0. DHHS 31st March 2003, 2003.
6. J.T. Hickok, J.A. Roscoe, G.R. Morrow, K. Mustian, P. Okunieff, and C.W. Bole Frequency, severity, clinical course, and correlates of fatigue in 372 patients during 5 weeks of radiotherapy for cancer Cancer 104 2005 1772 1778
7. A.B. Karim, B. Maat, and R. Hatlevoll A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844 Int J Radiat Oncol Biol Phys 36 1996 549 556
8. G.M. Kiebert, D. Curran, and N.K. Aaronson Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group Eur J Cancer 34 1998 1902 1909
9. B.A. Jereczek-Fossa, L. Santoro, and D. Alterio Fatigue during head-and-neck radiotherapy: prospective study on 117 consecutive patients Int J Radiat Oncol Biol Phys 68 2007 403 415
10. K. Bjordal, S. Kaasa, and A. Mastekaasa Quality of life in patients treated for head and neck cancer: a follow-up study 7 to 11 years after radiotherapy Int J Radiat Oncol Biol Phys 28 1994 847 856
11. A. Eardley Patients and radiotherapy. 3. Patients' experiences after discharge Radiography 52 1986 17 19
12. L. Veldeman, I. Madani, F. Hulstaert, G. De Meerleer, M. De Mareel, and W. Neve Evidence behind use of intensity-modulated radiotherapy: a systematic review of comparative clinical studies Lancet Oncol 9 2008 367 375
13. M. Goitein How best to dispose of extra-tumoral dose: a cautionary note for intensity-modulated radiation therapy Int J Radiat Oncol Biol Phys 75 2009 1 3
14. D.I. Rosenthal, M.S. Chambers, and C.D. Fuller Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer Int J Radiat Oncol Biol Phys 72 2008 747 755
15. F.M. Fang, C.Y. Chien, and W.L. Tsai Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy - a longitudinal study Int J Radiat Oncol Biol Phys 72 2008 356 364
16. P. Graff, M. Lapeyre, and E. Desandes Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy Int J Radiat Oncol Biol Phys 67 2007 1309 1317
17. C.M. Nutting, J.P. Morden, and K.J. Harrington Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial Lancet Oncol 12 2011 127 136
18. C.H. Clark, E.A. Miles, and M.T. Urbano Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer Br J Radiol 82 2009 585 594
19. M.T. Guerrero Urbano, C.H. Clark, and C. Kong Target volume definition for head and neck intensity modulated radiotherapy: pre-clinical evaluation of PARSPORT trial guidelines Clin Oncol (R Coll Radiol) 19 2007 604 613
20. C.H. Clark, V.N. Hansen, and H. Chantler Dosimetry audit for a multi-centre IMRT head and neck trial Radiother Oncol 93 2009 102 108
21. ICRU, ICRU Report 50. Prescribing, recording and reporting photon beam therapy. International Commission on Radiation Units and Measurements, 1993.
22. ICRU, ICRU Report 62. Prescribing, recording and reporting photon beam therapy (supplement to ICRU Report 50). International Commission on Radiation Units and Measurements, 1999.
23. H.R. Withers, H.D. Thames Jr., and L.J. Peters A new isoeffect curve for change in dose per fraction Radiother Oncol 1 1983 187 191
24. Y.R. Lawrence, X.A. Li, and N.I. El Radiation dose-volume effects in the brain Int J Radiat Oncol Biol Phys 76 2010 S20 S27
25. R Development Core Team R: a language and environment for statistical computing 2008 R Foundation for Statistical Computing Vienna, Austria
26. A. Jackson, E.D. Yorke, and K.E. Rosenzweig The atlas of complication incidence: a proposal for a new standard for reporting the results of radiotherapy protocols Semin Radiat Oncol 16 2006 260 268
27. A. Agha, M. Sherlock, and S. Brennan Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults J Clin Endocr Metab 90 2005 6355 6360
28. J.M. York, N.A. Blevins, and D.D. Meling The biobehavioral and neuroimmune impact of low-dose ionizing radiation Brain Behav Immun 26 2012 218 227
29. J.E. Bower, P.A. Ganz, and M.L. Tao Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer Clin Cancer Res 15 2009 5534 5540
30. J.P. Konsman, P. Parnet, and R. Dantzer Cytokine-induced sickness behaviour: mechanisms and implications Trends Neurosci 25 2002 154 159
31. E. Shaw, and M. Chan A phase II double-blind feasibility study of armodafinil for brain radiation-induced fatigue 2010 Comprehensive Cancer Center of Wake Forest University Community Clinical Oncology, Winston-Salem, NC NCI
32. C. Mayo, E. Yorke, and T.E. Merchant Radiation associated brainstem injury Int J Radiat Oncol Biol Phys 76 2010 S36 S41
33. B.S. Chera, R.J. Amdur, P. Patel, and W.M. Mendenhall A radiation oncologist's guide to contouring the hippocampus Am J Clin Oncol 32 2009 20 22